Background and Purpose-The ABCD 2 score predicts the early risk of stroke after transient ischemic attack. The early risk of recurrence after minor stroke is as high but the only validated prognostic scores for use in minor stroke predict long-term risk of recurrence: the Essen Stroke Risk Score and the Stroke Prognosis Instrument II. Methods-We determined the prognostic value of the ABCD 2 score, Essen Stroke Risk Score, and Stroke Prognosis Instrument II in a prospective population-based study in Oxfordshire, UK, of all incident and recurrent stroke (Oxford Vascular Study). Minor stroke was defined as an National Institutes of Health Stroke Scale score Յ5 at the time of first assessment. The 90-day risks of recurrent stroke were determined in relation to each score. Areas under the receiver operator curves indicated predictive value. Results-Of 1247 first events in the study period, 488 were transient ischemic attacks, 520 were minor strokes, and 239
A t least 48 000 transient ischemic attacks (TIAs) and 43 000 minor strokes are managed as outpatients each year in England alone and approximately 150 000 suspected TIAs and minor strokes are referred to secondary care for assessment and investigation, 1 with rates similar in the United States. 2 Recent hospital-and population-based studies have shown high early risks of recurrent stroke after TIA. [2] [3] [4] [5] [6] [7] Similar risks have been observed after minor stroke. 8 -10 Clinical risk scores have been developed to stratify and select patients at highest risk of early recurrence after TIA. One such score, the ABCD score, is based on clinical characteristics detected at the time of first assessment. This score has been refined further to include diabetes (ABCD 2 ) 11 and more recently imaging (ABCD 2 -I) and has been incorporated into clinical guidelines to assist triaging and risk stratifying patients. [12] [13] [14] The ABCD 2 score is now recommended for use in triaging patients with suspected TIA, but its role in minor stroke is yet to be determined. [12] [13] [14] [15] [16] [17] Other validated clinical risk prediction tools exist for long-term risk of recurrent stroke after TIA or stroke. These include the Essen Stroke Risk Score (ESRS), a 10-point scale used to predict 1-year risk of recurrent stroke derived from the data subset of 6433 cerebrovascular patients in the Clopidogrel versus Aspirin in patients at Risk of Ischemic events (CAPRIE) trial, 18, 19 and the Stroke Prognosis Instrument II (SPI-II) a 15-point score consisting of 7 factors used to predict 2-year risk of recurrent stroke validated in 4 test cohorts, 20 but neither has been validated for 90-day risk of stroke recurrence. In addition, previous validations were based on data collected from trials in which patients were recruited weeks or months after the initial event, which would not therefore have included many early recurrences. The aim of our study was to determine whether the ABCD, 2 ESRS, and SPI-II scores were predictive of recurrence in the acute and subacute phases for patients presenting with minor stroke.
Methods
The Oxford Vascular Study (OXVASC) is a population-based study of all stroke and TIAd in 91 105 individuals of all ages registered with 63 general practitioners in Oxfordshire, UK. This article includes all events ascertained from April 1, 2002, to March 31, 2007 . The study methods have been described elsewhere. 21, 22 Briefly, multiple overlapping methods of "hot" and "cold" pursuit were used to achieve near complete ascertainment of all individuals with TIA or stroke. [21] [22] [23] These include: (1) a daily weekday, rapid access "TIA clinic" to which participating general practitioners and the local accident and emergency department refer all individuals with suspected TIA or minor stroke whom they would not normally admit directly to the hospital; (2) daily searches of admissions to the medical, stroke, neurology, and other relevant wards; and (3) daily searches of the local accident and emergency department attendance register.
To not miss patients who presented late or had events out of the area, patients who were referred to other services, or patients who were not referred to secondary care, we also performed monthly computerized searches of family doctor diagnostic coding, hospital discharge codes, and all cranial and carotid imaging studies performed in local hospitals.
All patients were consented and seen by study physicians as soon as possible after their initial presentation. Overall, 70% were seen within 24 hours of the onset of symptoms. Event characteristics and risk factors were recorded and most patients underwent brain imaging (91%). All cases were subsequently reviewed by the study senior neurologist (P.M.R.) and classified using SDs. 21, 22 All patients were followed up formally face to face by a study nurse or physician. Recurrent symptoms, medications, and disability scores were recorded. Recurrent strokes that presented to medical attention would also be identified acutely by ongoing daily case ascertainment within OXVASC.
Baseline characteristics were recorded in all patients and assessments were made for severity of event (using National Institutes of Health Stroke Scale 24 ), territory, and clinical features. All patients with recurrent events were reassessed by a study physician and then case-reviewed by P.M.R. with most receiving repeat brain imaging. Severity of the recurrent event was based on clinical examination at the time of assessment by the study physician.
Analysis
We restricted analysis to the risk of stroke after the first minor stroke in the study period. Events were classified as minor stroke if there was a focal neurological deficit lasting Ͼ24 hours and a National Institutes of Health Stroke Scale score Յ5 at the time of assessment by a study physician. A cutoff of National Institutes of Health Stroke Scale score Յ5 was chosen because this included the majority (97%) of strokes seen in the outpatient setting. The study denominator and recurrence rate were defined both from time of the event that led to presentation and from the time that the patient first sought medical attention. We included patients regardless of whether they sought medical attention for their initial symptoms, that is, if patients described symptoms of acute onset focal neurological deficit consistent with minor stroke preceding the presenting event but had not sought medical attention. However, we analyzed the risk of stroke within 7 and 90 days after minor stroke both including and excluding patients who did not seek medical attention for their initial symptoms and only presented after the recurrent stroke. In the analysis excluding patients who only sought medical attention after a recurrent stroke, 508 (98%) patients were prospectively assessed before the recurrent stroke. Of the 61 recurrent strokes, 49 (80%) were prospectively assessed before their recurrence.
A recurrent stroke was defined as a new and persistent neurological symptom in a patient in whom the initial symptoms had already substantially or fully recovered; most of these patients had repeat brain imaging.
The risk of recurrent stroke was stratified by the 3 scores: (1) the ABCD 2 score, a validated clinical risk prediction tool for triage assessment of TIA from 2 to 7 days, 7,11 was calculated as follows: ABCD 2 scoreϪage Ͼ60 yearsϭ1, blood pressure Ͼ140 and/or Ն90 mm Hgϭ1, clinical: unilateral weaknessϭ2, speech disturbanceϭ1, duration of symptoms: Ն60 minutesϭ2, 10 to 59ϭ1, Ͻ10 minutesϭ0 and diabetes presence of whichϭ1; (2) the ESRS, a validated 10-point linear scale to predict 1-year risk of recurrent stroke: age Ͼ75 years (2 points), Ն65 to 75 (1 point), arterial hypertension (1 point), diabetes mellitus (1 point), previous myocardial infarction (1 point), other cardiovascular disease except myocardial infarction and atrial fibrillation (1 point), peripheral arterial disease (1 point), current or past smoking Ͻ5 years (1 point), and previous TIA or ischemic stroke in addition to qualifying event (1 point). The score was categorized to low risk (0 to 2) and high risk (Ն3); and (3) the SPI-II, a validated 15-point score of 7 factors validated for 2-year risk of recurrent stroke after TIA and minor stroke: congestive heart failure (3 points), prior stroke (3 points), diabetes (3 points), age Ͼ70 years (2 points), stroke for the index event (2 points), hypertension (1 point), and coronary artery disease (1 point). Risk Groups I, II, III comprised patients with 0 to 3, 4 to 7, and 8 to 15 points, respectively.
Areas under the receiver operator curves and 95% CIs were calculated as a measure of predictive ability with ideal prediction producing a value of 1.00, whereas no better than chance prediction is represented by 0.50. Probability values that we quote are based on the difference between the observed predictive value (AUROC) and chance (ie, no predictive value).
Results
Of 1247 first events in the study period, 488 were TIAs, 520 were minor strokes, and 239 were major strokes. The mean age at first event was 73 years (range, 24 to 98 years). Forty-seven percent of patients were female. There were 142 recurrent strokes within 90 days (81, 111, and 142 within 7, 30, and 90 days, respectively).
Of the 142 recurrent strokes within 90 days of a first event, 72 (51%) were preceded by a TIA, 61 (43%) by a minor stroke, and 9 (6%) by major strokes. The 90-day risks of stroke after TIA, minor stroke, and major stroke were 14.8% (11.7 to 17.9), 11.7% (9.0 to 14.4), and 3.8% (1.4 to 6.2), respectively. Table 1 shows the baseline characteristics of all cases of minor stroke. Data were missing on blood pressure at first assessment in 6 patients to complete calculation of the ABCD 2 score leaving 514 of 520 patients with minor stroke (99%). 
Discussion
Minor strokes account for a significant proportion of patients with acute cerebrovascular events 1 and the early risk of recurrence is similar to that after TIA. 8 Although the ABCD 2 score has been shown to be effective in prediction of recurrent stroke after TIA in the acute phase, 11,24 -26 our study has shown that it is a relatively poor predictor of recurrent stroke after minor stroke up to 90 days and that neither the ESRS nor the SPI-II was predictive. Previous studies of clinical risk scoring in minor stroke have varied in methodology with most excluding the acute phase and also those patients who may have had a preceding event for which they did not seek medical attention before hospital admission. 10, 18, 20, 27 They also vary in population size, follow-up, and completeness of case ascertainment within the defined population. We performed the first prospective population-based study of risk scoring in patients with minor stroke.
Although the ABCD 2 score was modestly predictive after minor stroke, 1 argument is that the score may act as a diagnostic tool to identify patients more likely to have a true TIA or minor stroke because diagnosis is not completely reliable 28 and some patients with seizure or migraine are indistinguishable from those due to brain or retinal ischemia. 29 However, diagnostic accuracy is likely to be greater in patients with minor stroke compared with those with transient symptoms. Moreover, previous work has shown that in analysis limited to neurologist-confirmed TIA, the ABCD 2 score remains predictive. 11 Also, in a recent multicenter international collaborative analysis of patients with diffusionweighted imaging-positive TIA, the ABCD 2 score was still predictive of early recurrent stroke. 30 In a univariate analysis of the individual components of the ABCD 2 score, vascular risk factors, and Trial of ORG 10172 in Acute Stroke Treatment criteria, only hypertension and large artery disease were predictive of recurrent stroke with a nonsignificant trend for a combination of motor and speech symptoms, diabetes, and anterior circulation of event. In a recent prospective hospital series by Ois et al, recurrence after minor stroke was associated with the presence of weakness, speech disturbance, high alcohol intake, previous TIA, and severe symptomatic extra-or intracranial arterial disease. 10 Cerebral and vascular imaging studies could enhance prediction of stroke after minor stroke. The presence of new ischemic lesions on MRI or CT has been associated with an increased short-term risk of stroke as has severe symptomatic arterial disease. 10,31-33 Our study did not look at the role of MRI in improving risk stratification in patients with minor stroke. However, MRI as the first and immediate assessment tool is not yet commonplace in daily clinical practice. 34 One benefit of purely clinical scoring systems with simple, easily obtainable information is that they can be used at the point of first presentation to facilitate rapid triage by first-line healthcare professionals. Further research is required to determine whether newer technologies such as biomarkers of cerebral ischemia or thrombosis can add prognostically useful information in patients presenting with minor stroke.
Our study had some potential limitations. First, we cannot be completely precise about the risk of stroke in the acute phase because an unknown proportion of patients with minor stroke will never seek medical attention. Second, we might have underestimated the early risk of stroke slightly because some patients with major stroke with a preceding minor stroke may not have been identified because we excluded those in whom it was impossible to obtain a definite history of TIA or minor stroke because they were aphasic, confused, or unconscious. Third, our validation of the clinical scores for recurrences in the acute phase was based on relatively small numbers of outcomes and so further studies would help to confirm or refute our findings. Fourth, our study included some patients recruited into the Effect of urgent treatment of transient ischemic attack and minor stroke on early recurrent stroke (EXPRESS) study, 9 Phase 2, which involved more urgent investigation and treatment and which will have reduced the absolute risk of events and possibly influenced the association with particular risk factors.
In summary, although the ABCD 2 score is highly predictive of recurrent stroke after TIA in the acute phase, it is less predictive after minor stroke, and neither the ESRS nor the SPI-II predict 90-day recurrence. More reliable early prediction after minor stroke is required. 
